We are monitoring the impact of COVID-19 on Europe Hemostats Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4991
Share on
Share on

Europe Hemostats Market Research Report - Segmented By Product Type, Application, Distribution Channel and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe) - Industry Analysis, Size, Share, Trends and Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4991
Pages: 145

Europe Hemostats Market Size (2020 to 2025)

The size of the Europe Hemostats market is forecasted to be USD 850 million in 2020. It is expected to grow at a CAGR of 6.1% from 2020 to 2025. It captures 25% of the global market.

The increase in the number of surgical procedures will drive the growth of the market. The wide range of applications, continuous advancements in the product portfolio, technological advances that facilitate end-users, and assurance support to manufacturers to promote tissue sealants are the main drivers of the European hemostatic market. Chronic conditions and an aging population leading to an increased number of surgeries, advancements in technology, an increasing number of minimally invasive surgeries, and improved healthcare spending are said to drive the growth rate of the hemostats market in Europe. Moreover, it presents lucrative growth opportunities due to unmet medical needs and emerging healthcare market conditions. 

However, surgeons' reluctance to new products and low reimbursement may hamper the growth of the market. Much of the market has been consolidated, and this is a significant factor holding back the market.

This research report on the European Hemostats Market has been segmented and sub-segmented into the following categories:

  • By Product Type: Topical Hemostats, Tissue Sealants, Cyanoacrylate-based Tissue Adhesives, and Adhesion Prevention Products
  • By Application: Wound Closure and Surgical Hemostats
  • By Distribution Channel: Direct Tenders and Retail
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe

Regional Analysis:

The European Hemostats market is the second largest in the global market. The UK is the market leader. The growth of the European hemostats market is attributed to the increase in surgical procedures and the increase in the number of hemostatic product insurance providers. Despite this, the high cost of hemostatic devices hinders the market. In 2020, the European hemostats market represented 22.4% of the global hemostats market. Over the years, these products have been used in surgeries to stop bleeding in a short time. These products are biodegradable, absorbable, and cost-effective. They have a maximum stay of 3 years without adverse effects. This market is segmented and forecasts based on product type and geography. The type consists of thrombin-based, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. Here, thrombin-based hemostats dominate the European hemostats market.

Germany has a substantial market for hemostats and tissue sealants. The country has seen a significant escalation of the older adults' population and the latest devices' systematic launch. The penetration of these products would increase and drive the growth of the market if they were also used for multiple conditions.

Key players operating in the Europe Hemostats Market profiled in this report are 3M, ADCO Europe, Inc., Abbott Laboratories. Other players in the market include Advanced Medical Solutions Group, Plc. and Dymax Corporation.

1. Introduction         

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods   

               1.4 General Study Assumptions                 

2. Research Methodology                   

               2.1 Introduction      

               2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

               2.3 Analysis Design 

               2.4 Study Timeline  

3. Overview              

               3.1 Executive Summary                

               3.2 Key Inferences  

               3.3 Epidemology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

               4.1 Market Drivers  

               4.2 Market Restraints                   

               4.3 Key Challenges  

               4.4 Current Opportunities in the Market               

5. Market Segmentation                     

               5.1 Product Type     

       5.1.1 Introduction           

       5.1.2 Topical hemostats

                      5.1.2.1 Collagen-based topical hemostats

                      5.1.2.2 Oxidized regenerated cellulose-based topical hemostat

                      5.1.2.3 Gelatin-based topical hemostat

                      5.1.2.4 Thrombin-based topical hemostat

                      5.1.2.5 Combination topical hemostat

       5.1.3 Tissue Sealants      

                      5.1.3.1 Fibrin sealants

                      5.1.3.2 Protein-based sealants

       5.1.4 Cyanoacrylate-based tissue adhesives         

       5.1.5 Adhesion prevention products        

       5.1.6 Y-o-Y Growth Analysis, By Product Type     

       5.1.7 Market Attractiveness Analysis, By Product Type    

       5.1.8 Market Share Analysis, By Product Type     

               5.2 Application                 

       5.2.1 Wound Closure     

       5.2.2 Surgical Hemostats             

       5.2.3 Y-o-Y Growth Analysis, By Application         

       5.2.4 Market Attractiveness Analysis, By Application       

       5.2.5 Market Share Analysis, By Application        

               5.3 Distribution Channel      

       5.3.1 Direct Tenders       

       5.3.2 Retail        

       5.3.3 Y-o-Y Growth Analysis, By Distribution Channel       

       5.3.4 Market Attractiveness Analysis, By Distribution Channel     

       5.3.5 Market Share Analysis, By Distribution Channel      

               5.4 End User                     

       5.4.1 Hospitals  

       5.4.2 Ambulatory Centers            

       5.4.3 Community Healthcare      

       5.4.4 Clinics       

       5.4.5 Y-o-Y Growth Analysis, By End User             

       5.4.6 Market Attractiveness Analysis, By End User            

       5.4.7 Market Share Analysis, By End User             

6. Geographical Analysis                     

               6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                      6.1.3.1 By Geographical Area

                      6.1.3.2 By Product Type

       6.1.4  Market Attractiveness Analysis      

                      6.1.4.1 By Geographical Area

                      6.1.4.2 By Product Type

       6.1.5  Market Share Analysis       

                      6.1.5.1 By Geographical Area

                      6.1.5.2 By Product Type

               6.2 U.K                

               6.3 Spain    

               6.4 Germany                     

               6.5 Italy      

               6.6 France                         

7. Strategic Analysis               

               7.1 PESTLE analysis 

       7.1.1 Political    

       7.1.2 Economic 

       7.1.3 Social        

       7.1.4 Technological        

       7.1.5 Legal         

       7.1.6 Environmental       

               7.2 Porter’s Five analysis      

       7.2.1 Bargaining Power of Suppliers         

       7.2.2 Bargaining Power of Consumers     

       7.2.3 Threat of New Entrants      

       7.2.4 Threat of Substitute Products and Services

       7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                

               8.1 Johnson & Johnson Services, Inc.                     

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments        

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

               8.2 C. R. Bard, Inc.  

               8.3 Baxter  

               8.4 B. Braun Melsungen Ag

               8.5 Pfizer Inc.                   

               8.6 Vascular Solutions, Inc.                        

               8.7 Gelita Medical Gmbh     

               8.8 Equimedical               

               8.9 Integra Lifesciences Holdings Corporation                    

               8.10 Z-Medica, LLC

9. Competitive Landscape                  

               9.1 Market share analysis    

               9.2 Merger and Acquisition Analysis

               9.3 Agreements, collaborations and Joint Ventures   

               9.4 New Product Launches  

10. Market Outlook and Investment Opportunities                  

Appendix                   

               a) List of Tables                

               b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Hemostats Market, By Product Type, From 2020 to 2025 (USD Billion)
  2. Europe Topical hemostats Market, By Region, From 2020 to 2025 (USD Billion)
  3. Europe Tissue Sealants Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Cyanoacrylate-based tissue adhesives Market, By Region, From 2020 to 2025 (USD Billion)
  5. Europe Adhesion prevention products Market, By Region, From 2020 to 2025 (USD Billion)
  6. U.K. Hemostats Market, By Product Type, From 2020 to 2025 (USD Billion)
  7. Germany Hemostats Market, By Product Type, From 2020 to 2025 (USD Billion)
  8. France Hemostats Market, By Product Type, From 2020 to 2025 (USD Billion)
  9. Italy Hemostats Market, By Product Type, From 2020 to 2025 (USD Billion)
  10. Spain Hemostats Market, By Product Type, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample